International Paper
IP
$33.19
-1.45%
International Paper is one of the world's largest fiber-based packaging companies, manufacturing corrugated containers, containerboard, and pulp products while holding roughly one-third of the North American corrugated packaging market and a substantial European footprint following its acquisition of DS Smith. The company is best characterized as a scale-driven, vertically integrated commodity converter — a cost-curve player whose earnings are dictated by containerboard pricing, mill utilization, and input costs rather than by product differentiation. The current investor debate centers on the DS Smith integration and the resulting balance-sheet strain, with a Q4 2025 impairment-driven loss of $2.38 billion and a subsequent Q2 2026 net loss of $12 million raising questions about whether the European assets are worth keeping. Management's exploration of a potential sale of the European packaging business, which triggered a sharp relief rally in mid-October 2026, has become the dominant near-term catalyst, set against persistently weak North American demand and a 11.3% year-over-year revenue decline.…
IP
International Paper
$33.19
Related headlines
Investment Opinion: Should I buy IP Today?
Rating: Hold. The core thesis is that IP is a deeply cyclical converter undergoing a messy integration, with a potential European divestiture as the key value-unlocking catalyst. The analyst consensus rating of 1.58 (Buy) and average target of $45.09 imply 32.4% upside, but this is contingent on a successful asset sale and margin recovery that are not yet evident.\n\nSupporting evidence includes the depressed valuation (0.835x PS vs. historical 2.1x–4.1x), forward PE of 11.16x on consensus EPS of $3.86, and a 4.70% dividend yield. However, revenue is declining at 11.28% YoY, operating margins are near zero, and FCF does not cover the dividend. The stock's 26.99% one-year decline and -40.27% max drawdown reflect these fundamental challenges.\n\nKey risks include failure to sell the European business, continued North American demand weakness, and a dividend cut. The rating would upgrade to Buy if the European sale is announced at a favorable price (e.g., above 8x EBITDA) and North American volumes stabilize. It would downgrade to Sell if the sale falls through and revenue declines accelerate below -15% YoY. Relative to history and peers, the stock is undervalued on PS and P/B, but the discount is justified by negative margins and integration risk; fair value is likely in the mid-$30s until catalysts materialize.
Sign up to view all
IP 12-Month Price Forecast
The risk/reward is balanced but with high uncertainty. The stock is deeply undervalued on historical metrics, and the European sale could be a transformative catalyst, but the core business is deteriorating and the dividend is at risk. The analyst consensus is bullish, but targets may be stale. I would upgrade to bullish if the European sale is announced at a favorable price and North American volumes stabilize; I would downgrade to bearish if the sale fails and revenue declines accelerate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on International Paper's 12-month outlook, with a consensus price target around $45.40 and implied upside of +36.8% versus the current price.
Average Target
$45.40
0 analysts
Implied Upside
+36.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$35 - $62
Analyst target range
Coverage is solid with 11 analysts, and the consensus is bullish: a recommendation mean of 1.58 (Buy) with an average target price of $45.09, implying +32.4% upside from the current $34.05. The distribution skews positive, with recent actions including Deutsche Bank's upgrade from Hold to Buy (July 31, 2026) and JP Morgan's upgrade from Neutral to Overweight (July 28, 2026), while UBS remains the lone Neutral. Consensus FY revenue of $27.04 billion and EPS of $3.86 imply analysts expect a meaningful second-half recovery that the trailing numbers do not yet corroborate.\n\nThe target range of $35.00 to $62.00 is extremely wide — a 77% spread from low to high — signaling high uncertainty about the European asset outcome and containerboard pricing. The $62 high target likely assumes successful EMEA divestiture at a premium, deleveraging, margin recovery toward mid-cycle levels, and multiple expansion back toward historical PS norms; the $35 low target essentially prices the stock at today's level, implying no credit for a turnaround and continued North American weakness. Notably, the low target of $35.00 sits above the current $34.05 price, meaning even the most bearish analyst sees modest upside — a mildly constructive signal — but the wide dispersion and the fact that targets were largely set around the July 31 earnings release (before the September decline to $31.70) suggest estimates may be stale relative to the recent price action.
Drowning in data?
Find the real signal!
Bulls vs Bears: IP Investment Factors
The bear case currently has stronger evidence: revenue is declining at a double-digit rate, margins are near zero, and free cash flow does not cover the dividend, while the technical trend remains firmly negative. However, the bull case rests on a potential European divestiture that could deleverage the balance sheet and unlock value, supported by a deeply depressed valuation and analyst consensus expecting a recovery. The single most important tension is whether the European asset sale materializes at a favorable price—if it does, the stock could re-rate sharply; if it fails or is delayed, the downside risks intensify. Near-term, the stock is a show-me story with a binary catalyst.
Bullish
- Deep historical valuation discount: At 0.835x PS and 1.40x P/B, IP trades at the very bottom of its multi-year range (PS 2.1x–4.1x, P/B 1.19x–2.29x). This extreme compression prices in significant pessimism, offering substantial re-rating potential if margins normalize.
- Analyst consensus and target upside: 11 analysts rate IP a Buy (mean 1.58) with an average target of $45.09, implying 32.4% upside from $34.05. Even the lowest target of $35.00 sits above the current price, suggesting a favorable risk/reward skew.
- European divestiture catalyst: Management is exploring a sale of the European packaging business, which could deleverage the balance sheet and remove a persistent drag. The October 15 rally (+6.9% on high volume) signals the market views this as a value-unlocking event.
- Forward earnings recovery priced in: The forward PE of 11.16x versus a trailing loss implies consensus FY EPS of $3.86, a dramatic turnaround. If achieved, the stock would trade at a reasonable multiple for a cyclical recovery, supported by recent upgrades from Deutsche Bank and JPMorgan.
Bearish
- Persistent revenue contraction: Q2 2026 revenue fell 11.28% YoY to $6.004 billion, with North America (62% of sales) weak and EMEA (26%) under pressure. The top-line decline shows no sign of abating, undermining the earnings recovery thesis.
- Marginal profitability and cash burn: Q2 2026 net loss of $12 million and operating margin of just 0.75% highlight fragile profitability. TTM FCF of $492 million (2.4% yield) is insufficient to cover the $245 million quarterly dividend, forcing reliance on balance-sheet capacity.
- Balance sheet strain from DS Smith: Debt-to-equity of 0.729, ROE of -23.71%, and $1.535 billion of Q2 acquisition outflows have consumed financial flexibility. The current ratio of 1.279 is adequate but leaves little room for error.
- Severe technical downtrend: The stock is down 26.99% over one year and 15.40% YTD, massively underperforming the S&P 500. At $34.05, it sits 22.8% into its 52-week range, with a -40.27% max drawdown confirming structural damage.
IP Technical Analysis
International Paper is locked in a sustained downtrend, with the stock down 26.99% over the trailing year and 15.40% year-to-date, dramatically underperforming the S&P 500's +15.53% and +11.93% respective returns. At $34.05, the shares sit at roughly 22.8% of the 52-week range of $29.26 to $50.25 — deep in the lower quartile and only 16.4% above the 52-week low. This positioning reflects persistent distribution rather than a value base, and the -40.27% max drawdown confirms a structurally damaged chart where rallies have been sold repeatedly.\n\nShort-term momentum remains negative but is decelerating in severity: the stock is down 2.94% over one month and 9.35% over three months, versus a 26.99% one-year decline, indicating the pace of selling has moderated. Critically, the one-month relative strength of -1.25 against SPY's +1.22% is a far smaller gap than the -42.52 one-year relative strength figure, suggesting the stock is attempting to find a floor. The October 15 rally on European asset-sale speculation produced a sharp single-day move from $31.90 to $34.10 (+6.9%), a high-volume reversal candle that is the first meaningful bullish signal in months, though it remains unconfirmed.\n\nKey support rests at the $29.26 52-week low, with the $31.70–$32.00 zone acting as the immediate floor tested repeatedly in early October; a breakdown below $29.26 would signal a fresh leg lower and likely capitulation. Resistance is layered at $36.50–$37.00 (the September breakdown shelf) and then the $42–$44 area where the July–August distribution occurred, with the $50.25 52-week high representing the full recovery target. A beta of 0.889 means the stock is roughly 11% less volatile than the market, which is modestly defensive for position sizing, but the 8.38 short ratio and 5.5 million average volume imply that event-driven squeezes — such as a confirmed European sale — could produce outsized moves independent of market beta.
Beta
0.89
0.89x market volatility
Max Drawdown
-40.3%
Largest decline past year
52-Week Range
$29-$50
Price range past year
Annual Return
-32.4%
Cumulative gain past year
| Period | IP Return | S&P 500 |
|---|---|---|
| 1m | -7.0% | -1.0% |
| 3m | -21.3% | +2.9% |
| 6m | +1.7% | +6.5% |
| 1y | -32.4% | +13.1% |
| ytd | -17.5% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IP Fundamental Analysis
Revenue is contracting, not growing: Q2 2026 revenue of $6.004 billion fell 11.28% year-over-year from $6.767 billion in Q2 2025, and the sequential trend is flat-to-down ($5.971 billion in Q1 2026, $6.006 billion in Q4 2025). The segment mix shows Packaging Solutions North America at $3.702 billion, Packaging Solutions EMEA at $1.550 billion, and Global Cellulose Fibers at $643 million, meaning roughly 62% of revenue is exposed to the weak North American box market while the DS Smith-acquired European business contributes about 26%. The revenue trajectory implies the investment case is no longer about organic growth but about portfolio rationalization — divesting EMEA and defending North American price/mix — which caps the multiple until volume inflects.\n\nProfitability is marginal and volatile: Q2 2026 net income was -$12 million (EPS -$0.02) on a 27.65% gross margin, a sharp deterioration from Q1 2026's $60 million profit and 20.73% gross margin, and a world away from Q4 2025's -$2.384 billion loss driven by a $3.36 billion other-expense charge. The trailing net margin of -14.12% and operating margin of -11.33% are distorted by that impairment, but even the clean quarters show operating margins of just 0.75% (Q2 2026) and 2.91% (Q1 2026) — far below the mid-single-digit to low-double-digit operating margins typical of a normalized containerboard cycle. Gross margin has oscillated between 20.7% and 31.4% over four quarters, evidence of commodity price and input-cost whipsaw rather than stable pricing power.\n\nThe balance sheet is the central risk: debt-to-equity stands at 0.729, ROE is -23.71%, and ROA is just 1.59%, while the current ratio of 1.279 offers adequate but not comfortable liquidity. Free cash flow is the weak link — TTM FCF of $492 million against a $20.8 billion market cap yields only ~2.4%, and Q2 2026 FCF was actually -$7 million after $533 million of capex and $245 million of dividends, meaning the dividend (4.70% yield, payout ratio -27.8% on negative earnings) is being funded by balance-sheet capacity rather than organic cash generation. The $1.535 billion of Q2 acquisition outflows and $853 million ending cash position underscore that the DS Smith integration has consumed financial flexibility, making the potential European divestiture a deleveraging event as much as a strategic one.
Quarterly Revenue
$6.0B
2026-06
Revenue YoY Growth
-11.3%
YoY Comparison
Gross Margin
27.7%
Latest Quarter
Free Cash Flow
$492000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IP Overvalued?
Because trailing net income is negative (EPS -$0.169, trailing PE of -5.87x), the PE ratio is not meaningful and I am leading with the price-to-sales ratio of 0.835x and EV/Sales of 1.125x as the primary valuation anchors, supplemented by the forward PE of 11.16x. The gap between the meaningless trailing PE and an 11.16x forward multiple implies the market expects a dramatic earnings recovery — consensus FY EPS of $3.86 versus a trailing loss — which is a high bar given the 11.3% revenue decline and near-zero operating margins.\n\nAgainst a Basic Materials/Paper & Forest Products sector where mature packaging peers typically trade at 0.8x–1.2x sales and 10x–14x forward earnings, IP's 0.835x PS and 11.16x forward PE sit near the middle of the range — neither a clear discount nor a premium. The 1.40x price-to-book and 12.25x price-to-cash-flow are moderate, but the EV/EBITDA of -313.98x is distorted by the impairment-driven negative EBITDA and should be disregarded. On a clean forward basis, the valuation is roughly fair for a low-growth, cyclical converter, meaning there is no margin-of-safety cushion if the earnings recovery disappoints.\n\nHistorically, IP's PS ratio has ranged from roughly 2.1x (Q3 2022) to 4.1x (Q4 2024), and the current 0.835x reading is at the very bottom of that multi-year band — a level not seen in the provided history. The price-to-book of 1.40x is likewise near the low end of its 1.19x–2.29x historical range. This compression reflects genuine fundamental deterioration (negative margins, DS Smith integration costs) rather than simple multiple de-rating, so while the stock screens as historically cheap, the market is pricing in a lower-quality earnings base — the re-rating case depends entirely on margin recovery and successful EMEA divestiture.
PE
-5.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~84x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-314.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated. Revenue fell 11.28% YoY in Q2 2026 to $6.004 billion, with North America (62% of sales) weak and EMEA (26%) under pressure. Operating margin was just 0.75% in Q2 2026, and TTM FCF of $492 million (2.4% yield) is insufficient to cover the $245 million quarterly dividend, forcing reliance on balance-sheet capacity. Debt-to-equity stands at 0.729, and the current ratio of 1.279 offers limited cushion. The DS Smith integration has consumed $1.535 billion in Q2 acquisition outflows, leaving only $853 million in cash.\n\nMarket and competitive risks include valuation compression and cyclical demand. The stock trades at 0.835x PS, near the bottom of its historical range, but this reflects genuine fundamental deterioration rather than a temporary de-rating. Containerboard pricing remains weak, and North American box demand shows no clear inflection. Beta of 0.889 indicates modest market correlation, but the 8.38 short ratio and 5.5 million average volume suggest event-driven volatility. Recent news highlights the relief rally on European sale speculation, but the core North American business remains weak, making the stock a risky bet.\n\nThe worst-case scenario involves a failed European sale, continued North American volume declines, and a dividend cut. In this scenario, the stock could retest its 52-week low of $29.26, representing a 14.1% decline from $34.05. A more severe outcome, such as a recession-driven demand collapse, could push shares toward the analyst low target of $35.00 (which is above current price) or lower, with historical max drawdown of -40.27% implying a potential drop to ~$20.33. Investors could lose 14–40% from current levels in an adverse scenario.
FAQ
The most severe risk is financial: revenue is declining at 11.28% YoY, operating margins are near zero, and FCF of $492 million does not cover the $245 million quarterly dividend, raising the possibility of a cut. Competitive and market risks include weak North American containerboard demand and pricing pressure, which could delay any recovery. Company-specific risk centers on the European sale—failure to execute could trigger a re-rating lower. Macro risk is moderate given the 0.889 beta, but a recession would exacerbate volume declines.
Our 12-month forecast has a base case (50% probability) of $38–$45, assuming a gradual European sale process and stabilizing North American demand. The bull case (25%) targets $50–$62 on a successful sale and margin recovery, while the bear case (25%) sees $29–$35 if the sale fails and demand weakens. The most likely scenario is the base case, hinging on the European divestiture progressing and operating margins recovering to 3–5%.
IP appears undervalued on historical metrics: its PS ratio of 0.835x is at the bottom of its multi-year range of 2.1x–4.1x, and P/B of 1.40x is near the low end of 1.19x–2.29x. However, the discount reflects genuine fundamental deterioration, including negative net margins and integration costs. On a forward basis, the PE of 11.16x is roughly in line with peers, suggesting the market expects a recovery. The stock is not a screaming bargain unless the European sale unlocks value.
IP offers a compelling risk/reward for value-oriented investors, with a 32.4% upside to the average analyst target of $45.09 and a deeply depressed valuation of 0.835x PS. However, the core business is weak, with revenue down 11.28% YoY and operating margins near zero, and the dividend is not covered by free cash flow. The biggest downside risk is a failed European sale, which could push the stock to its 52-week low of $29.26 (14% downside). It is a good buy only for those with a high risk tolerance and a catalyst-driven thesis, ideally accumulating on weakness below $32.
IP is better suited for medium-term, event-driven investors rather than long-term buy-and-hold. The stock is in a structural downtrend with a -40.27% max drawdown, and the dividend is at risk, making it unsuitable for income-focused long-term portfolios. However, the potential European sale and deep valuation could reward patient investors over 12–24 months. Short-term traders may capitalize on volatility around news, but the high short ratio (8.38) and low beta (0.889) suggest limited momentum. A minimum holding period of 12–18 months is advisable to allow catalysts to play out.